A Pharmacy School In India Published This Herpes Study. Big Pharma Buried It.

A pair of plants from southern India demonstrated 100% suppression of the herpes virus in laboratory conditions. The research was published on the US Government's own medical database. So why are so few people talking about it?

JSS College of Pharmacy, Mysore — where independent research on Hypericum mysorense was first conducted.

Somewhere in the Western Ghats of southern India, a team of researchers at the JSS School of Pharmacy began studying a plant that had been used in traditional medicine for centuries — Hypericum mysorense. What they found in the lab may have quietly rewritten the conversation around herpes — at least for those paying close enough attention.

Their findings? In controlled laboratory conditions, extracts of Hypericum mysorense demonstrated 100% in-vitro suppression of the herpes virus. The study wasn't published in an obscure journal. It was published and indexed on PubMed — the US National Library of Medicine's official research database — where it has sat, publicly accessible, since 2009.

You might wonder: if a study like this exists on a government medical website, why haven't more people heard about it? Why hasn't your doctor mentioned it?

That's the question a growing number of people are starting to ask.

"The study has been on the US Government's own medical database since 2009. Could this be one of the most overlooked discoveries in herpes research?"

Big Pharma Noticed — Then Walked Away

It wasn't just small research teams paying attention. Reports suggest that major pharmaceutical companies took notice of the Hypericum findings and attempted to isolate and synthesize the active compounds for use in a mass-market drug.

The problem? The synthesized version didn't behave like the plant. Clinical trials were reportedly halted due to side effects — a pattern that has played out before with botanical compounds that lose something essential in the extraction-and-isolation process.

Whole plant. Whole picture. Could that be the part that matters?

Meanwhile, one company had been quietly working on something different — not a synthesized compound, but an in-vivo formulation using the plant as nature intended it.

A US Patent For Something That Grows Naturally

Biogetica — a holistic health company with roots in Integrative Medicine — spent years developing a formulation based on Hypericum mysorense and its botanical cousin, Hypericum hookerianum. Both plants were identified and studied by the JSS School of Pharmacy.

That formulation, called Hyperisince, received a US patent for its unique in-vivo approach — meaning it was formulated to work in the living body, not just in a petri dish.

US
Gov
NLM

Published Research — US National Library of Medicine (PubMed) Independent studies by JSS College of Pharmacy showed that extracts of Hypericum mysorense demonstrated significant anti-viral activity in vitro. Results are indexed on PubMed and have been publicly available since 2009.

What Did Patients Actually Report?

Published in the peer-reviewed International Journal of Research in Ayurveda and Pharmacy, a clinical study of Hyperisince documented patient-reported outcomes over several months. The numbers that emerged were, by any standard, worth a closer look.

76%

of patients reported zero outbreaks while using the formulation*

80%+

of patients using it for 4+ months reported never having another outbreak*

1–3

days — average healing time for outbreaks that did occur, per patient reports*

*Patient-reported outcomes from a peer-reviewed clinical study. Individual results may vary. These are not guarantees of any outcome.

Perhaps most striking: a majority of patients in the study rated Hyperisince 10 out of 10 and reported that outbreak duration and pain were noticeably less than with previously tried options — including prescription antivirals like Acyclovir.

Could a plant that's been growing in India for centuries genuinely outperform decades of pharmaceutical research? The patients in this study seemed to think so.

"A majority of patients rated it 10 out of 10 and reported better results than Acyclovir — the most commonly prescribed antiviral for herpes."

What Is The Biogetica Rescue Kit?

Biogetica's approach is not about a single ingredient. The Rescue Kit with Hypericum mysorense is a multi-spectrum kit designed to work across what Biogetica describes as the physical, energetic, and informational dimensions of immune health.

The kit includes Hyperisince (the patented Hypericum formulation), Reginmune (a natural immune support formula with Echinacea, L-Lysine, and Zinc), H-Factor (a homeopathic preparation), and Visarpa Clay (a traditional Ayurvedic topical for skin support during outbreaks).

It is produced in a GMP WHO-accredited facility in India and ships to customers across the United States and globally. Thousands of people have used it. Many of them had questions, just like the ones you may be asking right now.

Is It Worth Exploring?

That depends on what you've already tried, and what kind of answers you're looking for. If pharmaceutical options have left you frustrated, or if you're simply curious about what the research from JSS School of Pharmacy actually suggests for your own health — it may be worth reading more.

Biogetica's doctors are available for free online consultations, where they can walk you through the research, the kit contents, and whether this approach might make sense for you personally.

⚠️ Important: Biogetica's products are dietary supplements and not intended to diagnose, treat, cure, or prevent any disease. All patient outcomes referenced are self-reported from a peer-reviewed clinical study. Individual results will vary. Statements have not been evaluated by the FDA.

Curious About The Research?